Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Trial Profile

Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Mar 2016

At a glance

  • Drugs Atropine (Primary) ; Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Suxamethonium chloride (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Acronyms RocSugIO
  • Most Recent Events

    • 17 Mar 2016 New trial record
    • 11 Mar 2016 Primary endpoint has been met. (time needed to tracheal intubation), as per results published in the Anesthesia and Analgesia.
    • 11 Mar 2016 Results published in the Anesthesia and Analgesia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top